Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension: 1-Year Follow-up
- 28 May 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Journal of Perinatology
- Vol. 23 (4), 300-303
- https://doi.org/10.1038/sj.jp.7210908
Abstract
Although inhaled nitric oxide has been shown to reduce the use of extracorporeal membrane oxygenation, there is limited data on its effect on long-term outcomes. The purpose of our study is to report on the 1 year outcome of neonates treated with inhaled nitric oxide compared to a group of neonates who did not receive nitric oxide. We have previously reported on the in-hospital outcomes of 248 neonates who were >34 weeks' gestational age and were randomized to receive low-dose inhaled nitric oxide or placebo. Extracorporeal membrane oxygenation was used in 78 (64%) neonates in the control group and in 48 (38%) neonates in the inhaled nitric oxide group (p=0.001). We now report on the outcome of neonates followed to 1 year of age. Of the 248 neonates twenty-four (10%) died before 1 year of age. There was no difference in mortality between the two groups (11% in the control group and 9% in the inhaled nitric oxide group). Of the 224 surviving infants, we were able to contact the parents or guardians of 201 (90%) children. There were no intergroup differences in the numbers of patients reported as requiring medications for pulmonary disease (14% in the control group and 14% in the inhaled nitric oxide group) or the need for supplemental oxygen (1% in the control group and 0% in the inhaled nitric oxide group). The number of neonates reported to have an abnormal neurological examination or developmental delay was also similar in both groups (14% in the control group and 19% in the inhaled nitric oxide group). The use of low-dose inhaled nitric oxide reduces the use of extracorporeal membrane oxygenation without increasing the incidence of adverse outcomes to 1 year of age.Keywords
This publication has 12 references indexed in Scilit:
- Outcome in term infants treated with inhaled nitric oxideThe Journal of Pediatrics, 2002
- UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 yearsThe Lancet, 2001
- Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of The Neonatal Inhaled Nitric Oxide Study Group (NINOS)The Journal of Pediatrics, 2000
- Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 2000
- Recent developments in inhaled nitric oxide therapy of the newbornCurrent Opinion in Pediatrics, 1999
- Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter StudyPediatrics, 1998
- Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 1997
- Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenationThe Journal of Pediatrics, 1996
- Severe respiratory failure in neonates: Mortality and morbidity rates and neurodevelopmental outcomesThe Journal of Pediatrics, 1994
- Frequency of chronic lung disease in infants with severe respiratory failure treated with high-frequency ventilation and/or extracorporeal membrane oxygenationCritical Care Medicine, 1992